Keywords: pfizer, espana, sales, climb, spanish, subsidiary, drug
Pfizer Espana Sales Climb 19%
Article | 24 March 1998
Pfizer Espana, the Spanish subsidiary of the US drug giant, has postedsales of 26.7 billion pesetas ($172.5 million) for 1997, a rise of 19.3% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
